Stock listing
Medicenna Therapeutics Corp.
Selected listing: MDNA · TSX · CAD · CA
Medicenna Therapeutics Corp. (TSX:MDNA), Health Technology. Latest release Oct 5, 2026: Medicenna Announces Oral Presentation of Topline Data from the Phase…
- Ticker
- TSX:MDNA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TSX
- Currency
- CAD
About Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. is a public company listed on the Canadian market under the ticker MDNA. Medicenna focuses on developing innovative therapies for cancer treatment.
Latest news from Medicenna Therapeutics Corp.
Medicenna Announces Oral Presentation of Topline Data from the Phase 1/2 ABILITY-1 Study of MDNA11 at SITC 2026
October 5, 2026
Medicenna Announces Results of Annual General and Special Meeting of Shareholders
October 1, 2026
Medicenna Announces Oral Presentation of New Bizaxofusp Results in Recurrent Glioblastoma at the 2026 Society for Neuro-Oncology Annual Meeting
September 24, 2026
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
Medicenna Therapeutics Reports First Quarter Fiscal 2027 Financial Results and Announces Oral Presentations at Upcoming Conferences
August 14, 2026
Research Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. company profile
View the public company page for Medicenna Therapeutics Corp. on 6ix.
Medicenna Therapeutics Corp. news
Read company news and market updates connected to Medicenna Therapeutics Corp..
Medicenna Therapeutics Corp. investor events
Find investor webinars, events, and replay context for Medicenna Therapeutics Corp..